840 related articles for article (PubMed ID: 30340550)
1. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening: current practice, new developments, ethical challenges.
de Jong A; Maya I; van Lith JM
Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
[TBL] [Abstract][Full Text] [Related]
3. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
[TBL] [Abstract][Full Text] [Related]
4. Implementing non-invasive prenatal testing (NIPT) in the Netherlands: An interview study exploring opinions about and experiences with societal pressure, reimbursement, and an expanding scope.
Bakkeren IM; Kater-Kuipers A; Bunnik EM; Go ATJI; Tibben A; de Beaufort ID; Galjaard RH; Riedijk SR
J Genet Couns; 2020 Feb; 29(1):112-121. PubMed ID: 31710169
[TBL] [Abstract][Full Text] [Related]
5. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening: an ethical agenda for the near future.
de Jong A; de Wert GM
Bioethics; 2015 Jan; 29(1):46-55. PubMed ID: 25521973
[TBL] [Abstract][Full Text] [Related]
8. Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions.
Vanstone M; Cernat A; Nisker J; Schwartz L
BMC Med Ethics; 2018 Apr; 19(1):27. PubMed ID: 29661182
[TBL] [Abstract][Full Text] [Related]
9. A new ethical landscape of prenatal testing: individualizing choice to serve autonomy and promote public health: a radical proposal.
Munthe C
Bioethics; 2015 Jan; 29(1):36-45. PubMed ID: 25521972
[TBL] [Abstract][Full Text] [Related]
10. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
Zhytnik L; Peters M; Tilk K; Simm K; Tõnisson N; Reimand T; Maasalu K; Acharya G; Krjutškov K; Salumets A
Hum Reprod Update; 2021 Oct; 27(6):1056-1085. PubMed ID: 34329448
[TBL] [Abstract][Full Text] [Related]
11. Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access.
Bunnik EM; Kater-Kuipers A; Galjaard RH; de Beaufort ID
J Med Ethics; 2020 Mar; 46(3):194-198. PubMed ID: 31527142
[TBL] [Abstract][Full Text] [Related]
12. Ethics of routine: a critical analysis of the concept of 'routinisation' in prenatal screening.
Kater-Kuipers A; de Beaufort ID; Galjaard RH; Bunnik EM
J Med Ethics; 2018 Sep; 44(9):626-631. PubMed ID: 29695408
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey.
Kou KO; Poon CF; Tse WC; Mak SL; Leung KY
BMC Pregnancy Childbirth; 2015 Sep; 15():199. PubMed ID: 26330276
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
Minear MA; Alessi S; Allyse M; Michie M; Chandrasekharan S
Annu Rev Genomics Hum Genet; 2015; 16():369-98. PubMed ID: 26322648
[TBL] [Abstract][Full Text] [Related]
15. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
16. Unfair discrimination in prenatal aneuploidy screening using cell-free DNA?
Rolfes V; Schmitz D
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():27-29. PubMed ID: 26773245
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
[TBL] [Abstract][Full Text] [Related]
18. Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions.
van Schendel RV; van El CG; Pajkrt E; Henneman L; Cornel MC
BMC Health Serv Res; 2017 Sep; 17(1):670. PubMed ID: 28927451
[TBL] [Abstract][Full Text] [Related]
19. Financial contribution as reason to opt out of non-invasive prenatal testing.
Bet BB; Wielart L; Ravelli ACJ; van Wely M; van Leeuwen E; Pajkrt E
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():130-136. PubMed ID: 37311275
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens' attitudes.
Kater-Kuipers A; Bakkeren IM; Riedijk SR; Go ATJI; Polak MG; Galjaard RH; de Beaufort ID; Bunnik EM
Eur J Hum Genet; 2021 Jan; 29(1):2-10. PubMed ID: 32759960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]